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Introduction
A critical gap in the arsenal needed for planning HIV and 
tuberculosis (TB) programmes is a centralised source of 
standardised intervention cost data that is easily accessible 
to policy analysts, country officials, and implementing 
organisations planning programmes in low- and middle-
income countries. These data will support accurate planning, 
efficient implementation, and allocative efficiency. At the 
international level there are significant funding shortfalls to 
meet projected needs in both HIV and TB (Global Fund, 
2019; UNAIDS, 2016), while at the national level countries 
are contending with low levels of domestic resources, 
epidemics that are re-emerging (UNAIDS, 2018; WHO, 
2018), striving to meet expectations regarding universal 
health coverage, and transitioning away from multilateral 
aid (Chemouni, 2018; El-Sayed, Vail, & Kruk, 2018; Kharas 
& Noe, 2018; Prizzon, Rogerson, & Jalles d’Orey, 2017). 
However, there is a scarcity of standardised and easily 
accessible cost data needed to support the costing of 
national strategies and investment cases (Anderson, Maliqi, 
Axelson, & Ostergren, 2016; Government of India, 2017; 
Meyer-Rath et al., 2019), use in Global Fund applications, 
identify opportunities for sustainability, enable greater 
understanding of the costs of both illness and health care to 
patients and their families (Sweeney et al., 2018; Pillai et al., 
2019), and feed into economic evaluations and modelling, 
including the identification of potential inefficiencies 
(Bollinger, Sanders, Winfrey, & Adesina, 2017; Forsythe, 
Stover, & Bollinger, 2009).
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Consistently defined, accurate, and easily accessible cost data are a valuable resource to inform efficiency analyses, 
budget preparation, and sustainability planning in global health. The Global Health Cost Consortium (GHCC) 
designed the Unit Cost Study Repository (UCSR) to be a resource for standardised HIV and TB intervention cost 
data displayed by key characteristics such as intervention type, country, and target population. To develop the 
UCSR, the GHCC defined a typology of interventions for each disease; aligned interventions according to the 
standardised principles, methods, and cost and activity categories from the GHCC Reference Case for Estimating 
the Costs of Global Health Services and Interventions; completed a systematic literature review; conducted extensive 
data extraction; performed quality assurance; grappled with complex methodological issues such as the proper 
approach to the inflation and conversion of costs; developed and implemented a study quality rating system; and 
designed a web-based user interface that flexibly displays large amounts of data in a user-friendly way. Key lessons 
learned from the extraction process include the importance of assessing the multiple uses of extracted data; the 
critical role of standardising definitions (particularly units of measurement); using appropriate classifications of 
interventions and components of costs; the efficiency derived from programming data checks; and the necessity 
of extraction quality monitoring by senior analysts. For the web interface, lessons were: understanding the target 
audiences, including consulting them regarding critical characteristics; designing the display of data in “levels”; and 
incorporating alert and unique trait descriptions to further clarify differences in the data.
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Studies, in both the published and grey literature, 
report information inconsistently, making comparison and 
utilisation of the data difficult. Such inconsistencies include 
a lack of intervention typologies, as well as differences in 
defining outcome variables (i.e. the denominator in the unit 
cost), time horizons, and measurement of costs. The Global 
Health Cost Consortium (GHCC) was formed in 2016 to 
support achieving greater value for money of investments, 
through improving the availability, quality, timeliness and 
policy-relevance of HIV and TB cost information in low- and 
middle-income countries. As part of this support, in 2017 
the GHCC launched the Reference Case for Estimating the 
Cost of Global Health Services and Interventions (Vassall 
et al., 2017; hereafter “GHCC Reference Case”) to fill gaps 
in the availability and standardisation of costing guidelines 
applicable to multiple health areas, and to assist both 
producers and users of cost data to better conduct and 
interpret cost studies. 
In addition, the GHCC sought to build on earlier 
endeavours to address gaps in the availability and 
standardisation of published cost data. Between 2010–2013, 
these efforts for HIV resulted in the Avenir Health Unit Cost 
Repository (UCR) and the London School of Hygiene and 
Tropical Medicine (LSHTM) database described in the 
paper entitled Costs to Health Services and the Patient of 
Treating Tuberculosis: A Systematic Literature Review 
(Avenir Health, 2013; Laurence, Griffiths & Vassall, 2015). 
The GHCC performed an update of the included literature, 
standardised the categorisation of intervention and cost 
data, expanded the repository to include all HIV and TB 
interventions with available cost data, and redesigned the 
web-interface for additional functionality and adaptability to 
mobile platforms. Note that the development of the UCSR 
both informed and was informed by the GHCC Reference 
Case, which was being developed concurrently.1 Given the 
paucity of information on best practices for developing such 
repositories from published literature, particularly regarding 
methods for standardisation, extraction, data transformation, 
and web-interface design (Lund et al., 2011; Neumann et al., 
2016; Visscher et al., 2017), the development of the GHCC 
Unit Cost Study Repository (UCSR) is documented here so 
that users understand its strengths and limitations, and to 
assist those undertaking similar repository efforts that may 
be more localised or may be targeting other health areas.
Methods
Systematic search and review
HIV systematic search and review
GHCC collaborated with partners to identify 54 HIV 
interventions covering prevention, treatment and care, 
testing, enablers, and health systems. Using economic (e.g. 
“cost”, “care cost”) and disease-specific (e.g. “HIV”, “human 
immunodeficiency virus”) search terms, we conducted a 
systematic review of literature published without language 
restrictions between January 2006 and October 2017 
in six databases: PubMed, Embase, Web of Science, 
The Cochrane Library, The NHS Economic Evaluations 
Database, and Literatura Latinoamericana en Ciencias de 
la Salud (LILACS). There were no restrictions on the types 
of treatment or interventions, as the goal was to capture as 
many relevant studies as possible. An initial search focused 
on recent HIV intervention implementation was done for 
articles published from January 1, 2006 through October 2, 
2016. A follow-up search with the same databases was 
completed on October 20, 2017. We also used existing 
cost study databases from systematic reviews previously 
conducted by Avenir Health and LSHTM (Avenir Health, 
2013; Laurence et al., 2015), which expanded the set of 
identified HIV studies to include those published since 1993. 
A follow-up search of grey literature and a focused Google 
search was completed on July 31, 2018. 
Results from the systematic search were stored in an 
EndNote Library and merged with article lists previously 
obtained by Avenir Health and LSHTM, along with 
literature obtained from snowball searches. A team of 
four researchers screened the results, based on title and 
abstract, and senior researchers completed random checks 
of the excluded studies to identify potentially missed studies. 
The team excluded unique records if they were not from a 
low- or middle-income country, had no empirically collected 
data, were a commentary or letter to the editor, if the full-text 
of the record could not be found, or if the currency or 
perspective of the costing reported (from the article or after 
contacting authors) could not be ascertained in the full-text. 
All articles and reports were screened a second time during 
the extraction process to ensure that they contained the 
required empirical cost data. Ultimately, 175 peer-reviewed 
articles were selected and extracted from the initial 11 717 
unique records in the search (Figure 1). 
The grey literature search focused on relevant websites 
and literature referenced in published studies screened by 
the GHCC, while the Google searches focused on identifying 
specific interventions by region. After excluding duplicates 
and studies not meeting inclusion criteria, the grey literature 
search resulted in 38 reports. Focused Google searches 
were completed between November 2017 and July 2018 
with the following search string format: “‘[intervention name]’ 
costs [one of: Africa, Asia, East Europe]-US”.2 For example, 
a search string for female condom provision would be: 
“‘female condom provision’ costs Africa-US”. The first 20 
results for each region were reviewed by title and abstract, 
resulting in another four unique reports for inclusion. Of 
2 399 unique records screened, 42 grey literature reports 
were selected. In all, 1 344 unique unit cost estimates were 
obtained from 217 selected HIV studies.3 
TB systematic search and review
For TB, six health and economic databases were searched 
for studies published between January 1990 and July 28, 
2016 without language restriction: PubMed, EMBASE, 
Econlit, The National Health Service Economic Evaluation 
Database, The Cost-effectiveness Analysis Registry, and 
The Cochrane Library. Two additional databases, Web of 
Science and Literatura Latinoamericana en Ciencias de 
la Salud (LILACS), were searched in February and March 
2017. Broad searches were designed with search terms 
including economic (e.g. “cost”, “economic”, or “finance”), 
disease (e.g. “TB”, “tuberculosis”, “MDR”, “XDR”) and 
intervention-specific keywords (e.g. “treatment”, “DOTS”, 
“isoniazid preventive therapy”, “patient cost”).
The search results from each database were downloaded 
to Endnote into a single library. The screening of these 
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results, using the same exclusion criteria as for HIV, was 
then undertaken in three stages: by title, by abstract, and 
by full text. First, one person reviewed all records by title, 
while a second person checked the records that were 
excluded based on title screening. Second, the resulting 
abstracts were screened by two analysts independently 
and were excluded if no costs or cost sourcing were 
reported. The remaining records were then subject to a 
full-text review by two analysts working independently and 
assessed for eligibility. Records were also cross-checked 
against a recent systematic literature review of tuberculosis 
costs for health services and patients (Laurence et al., 
2015). Of 15 161 unique records, 170 were included 
(Figure 2). 
A search of the grey literature on TB was also 
conducted, aligned with the grey literature searches by 
the HIV team described above, through four principal 
databases: The European Association for Grey Literature 
Exploitation (EAGLE), The System for Information on 
Grey Literature in Europe (SIGLE), and the World Bank 
and WHO websites (documents and meeting reports). 
Google searches were also conducted, in which the 
first 50 documents that resulted from the algorithm used 
in Google for key websites, such as msf.org, who.int, 
unaids.org, and pepfar.gov, were reviewed. Although the 
OneHealth Tool, Resource Needs Model, Global Price 
Reporting Mechanism, Unit Cost Repository, and Unit 
Cost Estimations WHO-CHOICE tool were also searched, 
they did not contain unique cost information. The same 
screening process was followed as for the peer-reviewed 
literature, resulting in the inclusion of 31 TB grey literature 
studies from an original field of 398 unique records. 
Development of the extraction form
To develop the early version of the extraction form, an 
extraction working group was created within the GHCC 
team. This subgroup looked at both the extraction form that 
underpinned the former Avenir Health Unit Cost Repository, 
and the extensive Principles and Methods Reporting 
Checklist from the GHCC Reference Case to identify 
the fields needed for the UCSR. The extraction form was 
designed to serve multiple purposes: (a) designate and 
populate key fields to be displayed in the UCSR, (b) support 
a quality rating index and summary ratings to be displayed 
in the UCSR, and (c) facilitate analysis through including 
analysis-relevant fields not necessary for the UCSR 
display. It was recognised at the outset that standardisation 
of key intervention and cost characteristics was critical 
to presenting a reasonable number of filters (and filter 
drop-down options) in the UCSR, comparing data accurately, 
and avoiding errors that would impact programming (e.g. 
using both “Republic of Tanzania” and “Tanzania” for a 
country name). Achieving consensus across the GHCC 
team, advisors, stakeholders, and partners for filters and 
standardised options was a time-consuming process 
and continued even after extraction began. For example, 
drawing upon previous experience with the Avenir Health 
Unit Cost Repository and discussions with GHCC advisors 
and stakeholders, it was planned early in the process that 
the UCSR would be structured around disease-specific 
interventions, and that this list of interventions would need 
to align with how global partner organisations categorised 
interventions in their reporting and budgeting structures. 
However, each partner organisation did so differently, and 
therefore extensive research into these categorisations and 
Figure 1: PRISMA diagram for HIV
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database searching
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discussions with partner organisations were necessary to 
develop an “Intervention Typology”4 to frame the UCSR. 
The categories ultimately adopted were: Prevention; Case 
Detection, Testing, and Diagnosis; Treatment and Care; 
Enablers and Support; and Health System. 
A similar process was followed for the identification of other 
key extraction fields to be used as filters in the UCSR (e.g. 
target populations, service delivery platforms, ownership, 
technology, input cost categories, activity cost categories) as 
well as standardised drop-down options. Voluntary medical 
male circumcision (VMMC) and antiretroviral treatment 
(ART) interventions were used to pilot the extraction form 
and identify areas in need of standardisation. 
Several fields were standardised to better support the 
UCSR display and analysis. For example, author-reported 
country names were standardised into ISO-3 codes to 
ensure correct spelling. Additionally, the open-text field 
‘population’ was further divided and standardised into ‘target 
group – demographic’ and ‘target group – clinical’ to more 
clearly differentiate population groups across studies. The 
list of options for these fields was identified in a post-hoc 
analysis of author-reported information. Finally, the 
‘intervention details’ and ‘technology’ fields were separated 
from a free-text field to allow for searching capabilities on 
intervention characteristics in the UCSR. Some fields 
were dropped entirely. After lengthy discussion within the 
team, the ‘integrated services’ and ‘full/incremental cost’ 
fields were dropped due to the impossibility of specifying 
consistent operational definitions. Similarly, the field “traded 
vs non-traded” was dropped because the field was often 
noted as “mixed,” which stripped it of analytical value.  
Data extraction and cleaning process
Extracted cost data were recorded on two tabs of the 
extraction template Excel workbook: a study attributes 
tab, and a cost data tab. The study attributes tab records 
all study-level variables across columns (e.g. authorship, 
type of intervention, implementation of the intervention, 
costing methods, etc.), with each row representing a unique 
unit cost reported within a given study. Unit costs were 
determined to be unique and recorded in an individual row 
in the extraction form if reported in a study for different 
countries, target groups (demographic or clinical), service 
delivery platforms, ownership (e.g. public, private), urbanicity 
(e.g. rural, urban), sites, or technologies. The cost data tab 
in the extraction template records each cost type (total unit 
cost, input or cost category, or input cost) associated with 
a given row of the study attributes tab. If a row in the study 
attributes tab describes the unit cost of a male circumcision 
in the public sector, at a secondary-level hospital, using 
surgical technology, this row could then be associated with 
more than one cost data row if disaggregated cost data are 
Figure 2: PRISMA diagram for TB
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available. Thus, in addition to the total unit cost per person 
served for VMMC, there might also be separate rows for 
personnel cost, cost for recurrent goods, etc. 
All of the HIV articles and reports were divided among 
three extractors. The lead extractor managed version control 
across all interventions. For HIV, a senior team member 
verified or corrected all fields displayed in the UCSR. For 
TB, double extraction was performed by two teams of two 
extractors each. If there were discrepancies, these were 
first discussed among the two data extractors and verified 
against the study. If the data extractors could not agree, then 
a senior member of the team was consulted for resolution.
Standardising the data to a common currency and year 
(2017 USD) and format
Costs were standardised into 2017 United States Dollars 
(USD). All costs reported in currencies other than USD 
were converted to USD based on the year of reporting 
using market exchange rates published by the World Bank.5 
Once all costs were converted to USD, costs were inflated 
using the US GDP price deflator, as needed, also from the 
World Bank. For those studies that did not report the year 
of the cost data represented in the study, the “publication 
year minus- one year” was used before exchanging to USD 
(if applicable) and then inflating the reported costs to 2017 
USD. Alternative methods of these transformations were 
explored including using local inflation rates for some cost 
inputs before converting to USD (Kumaranayake, 2000) 
and are explained further in Annex A. Although, the method 
utilised by the GHCC (converting first to USD then inflating to 
2017 USD) risks masking important within-country variation 
in inflation over time for different categories of cost inputs in 
different contexts (Whiteside & Zebryk, 2017), we found that 
the reporting of cost data from original published articles was 
too heterogeneous in nature and that too many assumptions 
were necessary to justify using different inflation procedures 
for different cost inputs when not all inputs were uniformly 
available across articles. 
Data were combined into a single “wide file”6 for 
subsequent data analysis and exported to the UCSR. Data 
from both the study attributes and cost data tabs were 
imported into Stata in two separate Stata .dta files. Data 
from the cost data file were then merged field by field into 
the study attributes file so that each row represented a unit 
cost. Each row included the total unit cost, as well as the 
disaggregated input costs by a broad cost category (e.g. 
capital, personnel, traded goods, etc.) and a narrow cost 
category (e.g. personnel: direct service delivery; personnel: 
support staff) (Tables 1 and 2). 
Quality assurance
Validation of data extraction, transformations and 
programming
Quality assurance checks were performed during the 
workflow in five principal stages. In Stage 1, the completed 
extractions were reviewed for formatting errors, missing 
values, and other issues. A summary report for each 
intervention was then generated highlighting fields needing 
review by the team for standardisation (e.g. population 
and technology fields, and preferred output unit costs). 
These summaries were reviewed to achieve consensus on 
standardised options, after which the lead extractor updated 
the corresponding fields in the extraction.
In Stage 2, the vetted interventions were sent out for data 
validation checks in Stata 15 (described further below), 
which were developed jointly between Avenir Health and 
the data team after it was recognised that the files being 
sent for programming to the UCSR website contained 
numerous problems. These checks took about one day to 
run and flagged inconsistencies, misalignment, and errors 
in cost totals. Among numerous data checks, several that 
should be highlighted are: (a) checking to ensure that 
costs summed correctly; (b) reviewing any studies that 
omitted “critical costs”; (c) aligning the costed activities 
and intervention details fields to identify discrepancies (e.g. 
intervention elements that were included in the intervention 
but not costed, or vice versa); and (d) checking variable 
labels and names to ensure that they were standard 
across interventions, and not duplicative (e.g. HIV+ and 
HIV positive). Once this process was complete, flagged 
errors and a PDF summary showing the range of data/labels 
for each variable were sent back to extractors. 
Two additional fields for programming into the UCSR 
emerged from the Stage 2 review in (a) and (b) above. 
Although slight deviations between the total unit cost 
and the sum of the inputs were expected due to rounding 
errors and variations in how authors reported costs, or 
modifications from exchange rate changes, the consensus 
in the GHCC team was that a discrepancy of more than $1 
USD (remaining after review) should be flagged. It was also 
recognised that incomplete unit costs could be misleading to 
UCSR users. Thus, the GHCC determined, through analysis 
of the literature and of primary data sets, that key personnel, 
commodities, or services were “critical” cost inputs, and 
that where the author had reported omitting these from 
their reported total unit cost, those total unit costs should 
be flagged. Therefore, columns called “disaggregated costs 
flag” and “omitted costs” were created in the wide file, which 
feed into the alerts field of the UCSR display. 
In Stage 3, the extractors split up checking the extraction 
flags based on their respective familiarity with a given 
intervention. Depending on the number of flags, the clean-up 
process then took approximately one day. The flags were 
then reviewed and documented in a separate file. The 
cleaned extraction form was sent back for a final check 
prior to processing for the UCSR. In a parallel process, the 
cleaned interventions from cleaned intervention extractions 
underwent quality assurance (QA) by a senior researcher. 
This was an iterative process that took approximately 1.25 
hours per study, in parallel to the other stages in the process. 
When completed, the data in the wide file was then updated. 
In Stage 4, the data validation checks were then re-run, 
and any remaining flags were addressed by the extractors. 
Once cleaning was complete, the extraction file was 
transformed into four wide files (provider and patient cost 
files separately for HIV and TB) for use in the UCSR. In 
addition, intervention-specific wide files were sent to the 
GHCC analytics team for use in various analyses.
Finally, in Stage 5, the wide files were sent to Avenir 
Health for review and programmed into the UCSR using 
JavaScript and Highcharts. Once the system of Stata checks 
was in place, Avenir Health’s data check became more 
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focused on standardising between the TB and HIV wide files 
and probing where new fields should be added to support 
better user understanding of the cost. For example, fields on 
alerts (e.g. omission of key costs), number of sites included 
in the unit cost, and unique trait (i.e. why it is a unique cost 
within a study) were all added. Another review was done 
by Avenir Health after each iteration of the wide file was 
programmed into the UCSR to identify remaining issues and 
work with the programming and data teams to track the error 
source to either the UCSR programming, STATA coding for 
the wide file, or to the extraction itself, thereby circling back 
to stages 3, 4 or 5 again.
Development of the study quality rating index
The multi-component quality rating (QR) system was 
developed to provide the GHCC user with a nuanced 
quality assessment for HIV and TB intervention costing 
studies.7 This will help the user detect potential inaccuracies 
and assess his/her confidence in the displayed unit costs. 
Sixteen QR items were identified across four summary 
quality indicators — 1: Bias low (L; i.e. underestimation); 
2: Bias high (H; omitting or failing to appropriately account 
for key cost components resulting in overestimation); 3: 
Precision (P; the precision of the displayed unit cost); and 
4: Reporting standards (R; the extent to which the displayed 
unit cost conforms to the GHCC Reference Case reporting 
standards). For each identified QR item, 1–3 points are 
deducted depending on the field and the perceived impact 
of the magnitude of the problem, based on expert opinion 
within GHCC (Table 3). 
The final quality rating for each item is presented as a 
letter score A–D with A representing the highest quartile of 
scores and B–D representing the three successively lower 
quartiles. All items used were aligned with the definitions 
and topics outlined in the GHCC Reference Case. The 
system was validated against 14 published and commonly 
cited quality assessment tools, of which two are scoring 
systems for costing studies (Beck, Harling, Gerbase, & 
DeLay, 2010; DeCormier Plosky & Bollinger, 2012), and 12 
are cost-effectiveness analysis (CEA) checklists (Adams, 
McCall, Gray, Orza, & Chalmers, 1992; Chiou et al., 2003; 
Clemens et al., 1995; Drummond & Jefferson, 1996; Evers, 
Table 1: Broad and narrow input cost categories
Broad and narrow input cost categories Description of inputs in input cost categories
P
E
R
S
O
N
N
E
L Service delivery personnel Doctors, nurses, counsellors; Pharmacists; Lab/diagnostic personnel; Outreach workers, 
peer supporters, social workers; Community volunteers, or home visitors 
Support personnel Administrators, supervisors; Procurement officers, supply clerks, accountants; Legal staff; 
Receptionists; Social media coordinators, community strategy/mobilisation supervisors; 
Data and IT staff; Drivers; Gardeners; Security guards; Kitchen staff; Custodians or 
cleaning staff. 
C
A
P
IT
A
L
Lab/ diagnostic equipment Centrifuges, incubators, microscopes, water baths, orbital shakers; Xpert, X-ray, 
microscopy instruments, GeneChip scanner; Haemoglobin meters, urine analysers, liver/
renal biochemistry analysers.
Equipment (medical/intervention, excl. lab) Refrigerators, freezers; Incinerators and autoclaves; MEMS caps, monitoring equipment; 
Tents.
Equipment (non-medical/intervention) Furniture: beds, benches/couches, chairs, desks, tables, lamps/fixtures, filing/drug 
cabinets, bookcases; Computers, monitors, LCD projectors, printers; Software; Power 
outlets, or paper shredders. 
Vehicles, capital Bicycles; Motorcycles; Cars, vans or SUVs; Trucks; Boats; or Airplanes.
Building/space, capital Construction/purchased floor space in a health facility or training school; Truck containers; 
Storage facilities; Administrative offices; Wells; or Latrines.
Other capital Start-up training and materials; Licenses/copyrights. 
R
E
C
U
R
R
E
N
T
Supplies (key drugs) TB drugs; PrEP; ARVs; PEP; Hepatitis/STI/OI edication; Antibiotics; or Contraceptives.
Supplies (medical/intervention, excl. key 
drugs)
Vaccines; Syringes, test kits, sputum bottles, speculum, cotton swabs, microscope slides 
reagents; Gloves, gowns, masks, bandages; Small medical equipment; or Small containers 
to hold drugs.
Supplies (non-medical/non-intervention) Pens, pencils, dry-erase markers, highlighters; Printer paper, post-it notes, notebooks, 
calendars; Paper clips, binder clips; File folders; Envelopes, stamps; Tape, glue; Scissors, 
staplers, hole-punchers, calculators; Memory sticks; Batteries; or Lanyards.
Building/space Rent for capital inputs; Maintenance: Painting, roof, heating/plumbing, windows; Tires, 
spare parts, oil/lubricants, tune-ups; or Computer repair. Lighting, heating, water; 
Telephone, or internet.
R
E
C
U
R
R
E
N
T
Other recurrent Gasoline, fuel; Tolls; or Contracted transportation services; Food (at facilities/meetings; 
for nutritional support to improve health or lessen side effects of drugs); Vitamins, or 
Contracted meal services.
Recurrent training; Medical malpractice insurance; Insurance for capital building, vehicles, 
or equipment; Registration fees for capital items, for memberships in professional 
organisations, or for use of copyrighted materials for communication purposes (icons, 
photos, etc.); Contracted services such as laboratory, storage, waste removal (even if just 
burning and/or burying), security, or information technology if outsourced; Courier/UPS 
service; or Other recurrent costs.
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Table 2: Broad and narrow activity cost categories
Broad and narrow activity cost categories Description of example inputs in activity categories
PRIMARY SERVICE DELIVERY
Key activity 1
e.g. voluntary medical male circumcision procedure
Doctor, nurse; Disposable surgical kit, gloves, mask, gown 
Key activity 2
e.g. post-procedure check-up
Nurse; Gloves; Antibiotic cream
SECONDARY SERVICE DELIVERY
Secondary activity 1
e.g. HIV testing and counselling
Nurse; Antiseptic, cotton pad, needle, collection tube, HIV rapid test, bandages
Secondary activity 2
e.g. provision of condoms
Nurse; Condoms 
ANCILLARY SERVICE DELIVERY
Demand generation Communication coordinator, tech/web designer; Facebook ads, radio airtime
Lab services Lab service fee
Adherence/retention Cost per text message sent to remind clients of appointments, and to remind 
clients to use condoms during the healing period
OPERATIONAL
Buildings and equipment
Logistics
Supervision
Training
Transportation
Mass education
HMIS and record keeping
Technology development
Technology maintenance
Project management
Table 3: Study quality index indicators
Indicator Key components Points deductions
Bias low Above service delivery costs 3 points if no costs included. 1 point if “some costs included”
Overhead costs 2 points if not included
Personnel inefficiency/downtime adjustment 2 points if not adjusted or adjustment is “NR”
Valuing volunteer time 3 points if “none” or “NR”
Bias high Research costs 3 points if included in total cost
Time since program started 1 point if <6 months
Amortisation 1 point if not reported; 3 points if not amortised
Precision Sampling (geographic area, site, patient, 
as relevant)
• Maximum deductions of 3. 
• Deductions = (number of cells where geographical area, site, patient = “NR”) 
* 3/(3– [number of cells where geographical area, site, patient = “N/A”])
A deduction of 1 point is taken if the number of sites is 3–9.
A deduction of 1–3 points is taken if sampling method for geographical area 
sampling, site sampling, and/or patient sampling is listed as “convenience” or 
“not reported”. Please note that only the types of sampling applicable to the 
study design are included. For example, if geographical area sampling, site 
sampling, and patient sampling are listed as “N/A”, “NR”, “NR”, 3 points are 
deducted. If “N/A”, “N/A”, “NR”, 3 points are deducted. If “N/A”, “NR”, “reported 
– not convenience”, 1.5 points are deducted. If “N/A”,”N/A”, “reported – not 
convenience”, then no points are deducted.
Cost allocation method 3 points if “recall” or if “NR”
Resource identification 2 points if not micro-costing
Methods of measuring output 2 points if modelled, recall-interview/survey, or “NR”
Number of sites 2 points if <3 sites; 1 point if 3–9 sites
Reporting Urbanicity 2 points if “NR”
Ownership 3 points if not explicitly reported
Intervention components • GHCC has 15 columns for intervention components
• Maximum deduction of 3 points for these 15 components
• Deductions = (number of NR intervention components) * 3/15–(number of 
N/A intervention components)
Breakdown by activity 2 points if NR
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Goossens, de Vet, van Tulder, & Ament, 2005; Gerard, 1992; 
Grutters, Seferina, Tjan-Heijnen,  van Kampen, Goettsch, & 
Joore, 2011; Sacristán, Soto, & Galende, 1993; Sanders et 
al., 2016; Siegel, Weinstein, Russell, & Gold, 1996; Ungar 
& Santos, 2003; Weinstein, Siegel, Gold, Kamlet, & Russell, 
1996). The two scoring systems for costing studies compare 
with the GHCC QR system as follows: a) many items are 
similar, b) scoring rules for individual items differ in minor 
ways, and c) the Beck and Avenir Health systems provide 
single summary scores by summing numerical responses, 
while the GHCC system provides four ordinal ratings 
representing low and high biases, precision, and reporting.
Designing the UCSR web interface
The conceptual design of the UCSR web interface began 
soon following the GHCC project initiation, as it needed to 
align with principles and methods in the GHCC Reference 
Case, and because development of the extraction form 
needed to reflect the structure of the UCSR. The large and 
complex dataset underpinning the UCSR had to be easy to 
navigate by both costing experts and novices, provide the 
most important information needed to interpret varying cost 
estimates for the same intervention, follow standardised 
categorisations consistent with the monitoring and budgeting 
structures of GHCC partners to be useful for different costing 
purposes, and function smoothly on both desktop and 
mobile devices that may be utilising low-speed connections. 
Each element of the current UCSR design expressly 
reflects the lessons learned from: the previous Avenir Health 
Unit Cost Repository; the consensus-driven alignment 
and standisation processes to operationalise the GHCC 
Reference Case, intervention typology, and data extraction 
forms; comparisons of visualisation software platforms for 
cost and user training time; input from the GHCC team, 
GHCC stakeholders and advisors; numerous rounds of 
beta-testing (at the international level, country level, and 
within the Avenir Health programming team); a survey 
posted to the UCSR website and GHCC Newsletter; oral and 
written feedback after presentations at international/regional 
conferences and workshops; and a website design firm and 
a data visualisation specialist (Table 4).
Results
UCSR structure
The UCSR8 collates all published and grey literature 
cost estimates for HIV and TB interventions into one 
easily accessible online platform. The cost estimates are 
standardised in terms of output units (e.g. cost per person 
served, cost per visit), intervention implementation (e.g. 
service delivery platforms, ownership, target populations, 
technologies), disaggregated cost categories (e.g. 
personnel, capital costs), currency and year and costing 
perspectives. The final design requires the user to either 
utilise the Export Data feature to download the results for 
conducting their own external analysis and/or visualisations, 
or to get started on the Filter (Select) page by selecting 
one intervention that is defined further by disease and 
intervention class. This page allows for further filtering 
by geographic location (region/country, urbanicity) and 
target populations (demographic and clinical). The Filter 
(Refine) page provides additional filters for intervention 
implementation (platform, ownership, technology) and 
costing methodology (cost perspective, whether the cost is 
economic or financial, year of cost data collection, whether 
scale is discussed in the study, whether sensitivity analysis 
is performed in the study). 
The order of the filters reflects stakeholder preferences on 
the most important fields for the interpretation and utilisation 
of cost data and the order of principles in the GHCC 
Reference Case. Stakeholder feedback, through beta-testing 
multiple versions of the UCSR, provided critical input into the 
number of filters in the Filters pages to enhance and simplify 
the user experience. Also, limiting the choice on the Filter 
(Select) page to one intervention was intentional, to prevent 
overwhelming the user with an unmanageable number of 
filters, search results, and visualisation possibilities. 
Once the intervention is selected on the Filter (Select) 
page, the user clicks “apply” to see results on the results 
page. To simplify the presentation of information for 
the user, a two-level structure for display of results was 
developed. The first level is a simple table display listing 
the study (lead author/year of publication), unit cost in 2017 
USD, unit, alerts, unique trait, number of sites, perspective, 
country, technology detail, treatment phase (for treatment 
interventions only), demographic target group, clinical target 
group, platform detail, ownership, urbanicity, and quality 
rating. At this first level the user can also scroll to the right 
to view table columns not immediately visible on smaller 
screens, and filter further by a keyword or phrase in the 
search field (e.g. for “Xpert” within TB interventions). 
To access the second level of results, the user clicks 
on any unique unit cost row in the first level to see 
further information about that cost. This second level 
includes three main sections: (1) study attributes (citation, 
geography, intervention description, timing and coverage, 
population detail, study design, and costing methods); 
(2) cost disaggregation (input categories including
personnel, recurrent, etc., activity categories, and patient
cost categories); and (3) alerts (omitted costs, GHCC
calculations, and whether disaggregated costs sum to total
unit cost).
On the data visualizations page, UCSR users may create 
data visualisations by comparing results either by country 
or by a specific characteristic (e.g. platform, ownership). 
Note that the UCSR does not calculate an average cost 
or state which cost is preferable; rather the two-level 
display of results (e.g. unique trait, technology detail, cost 
disaggregation) and the visualisations respectively show the 
heterogeneities in, and the range of, costs for each country 
(including the median), using maps, bar charts, and box 
plots. Disaggregated costs can be displayed using either bar 
or pie charts by clicking on a unique cost estimate in the 
initial bar chart.
Averages are not calculated in the UCSR for various 
reasons: a) with the exception of standardising nomenclature 
and inflation/currency conversion to a common year and 
currency, the GHCC is a repository, representing the study 
data as reported; b) the average could be overly influenced 
by one study that has many estimates (such as for each 
facility studied); and c) a second tool, to be developed, was 
expected to calculate an “average” point estimate for the 
cost of each intervention in each country, on the basis of 
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Table 4: Best practices in constructing a cost repository
Practice Key components Reason
Know your 
audience
Determine how the data will be used (e.g. review, 
reporting, analysis)
To understand what level of detail will be necessary for data 
extraction (e.g. input cost categories, activity cost categories, 
specific input costs, costing methods) and what features will need 
to be built into a web repository (if put online).
Discuss what the data will be oriented around 
(i.e. the key or selection characteristic)
To align with budgeting, planning, grant application, and reporting 
frameworks, and/or inter-agency typologies; Design of web 
repository begins with key selection characteristic/filter.
Agree on a typology for that selection 
characteristic (e.g. if intervention, how to 
categorize interventions); Define what typically 
comprises each type of that characteristic (e.g. if 
HIV intervention, what is standard for a VMMC or 
ART intervention)
To align with budgeting, planning, grant application, and reporting 
frameworks, and/or typologies used across organizations; 
Engender comparability of cost data.
Agree to additional key characteristics to extract/
display; Determine what data users would like to 
see “first” in a spreadsheet or web-interface (i.e. 
how to “layer” the data)
To align with budgeting, planning, grant application, and reporting 
frameworks, and/or typologies used across organizations; Align 
with stakeholder needs for analysis and presentation of data; 
Display a limited number of characteristics in a user-friendly way.
Identify the software, hardware, platforms, 
and types of internet connection used by 
stakeholders
To determine the formats needed for download options (e.g. 
Excel, CSV, PowerPoint, JPG), the level of intricacy of data 
visualizations, the “user journey” (i.e. how a user scrolls and 
clicks through the website) on both desktop and mobile devices, 
and how large files (including photos, data) can be while meeting 
processing needs on low-bandwidth connections.
Create processes 
for communication 
within/among 
extraction and 
design teams and 
for quality control
Regular communication meetings within and 
among teams
The extraction can be subjective, and subject to more 
heterogeneous interpretation with more extractors. Therefore, 
regular communication is necessary for consistency.
Create documents to track the stage of review 
(included and excluded studies), extraction, 
quality control for each study (and for decision 
points that were made; Post these documents 
in a place (Dropbox, Smartsheet, Google Drive) 
accessible to all teams
This allows the team/s to be on the same page and prevents 
different extractors from doing [unplanned] duplicate extractions; 
Users of the study repository and study authors will want to know 
which studies are included, and the reasoning behind those 
excluded.
Double-extract or engage a senior staff member 
to review a sub-set of extractions; Automate data 
checks where possible
To assist with standardizing the extraction, to catch any extraction 
errors, and assess if extraction makes sense (e.g. average age 
entered in one column matches target population in another).
The person engaging with the web design team 
should be familiar with costing, and be able to 
both inform the design of the extraction template 
and review the collation of extracted data before 
uploading to the web
To align with needs of stakeholders and with costing guidance 
such as the GHCC Reference Case; To interpret the extraction 
and act as a check that the data is correct. *Note: The design 
team will need a collated extraction format that is easy to upload 
(e.g. Excel); going through Stata requires staff and programming.
Define and 
standardise 
extraction fields
Define each characteristic in the extraction To facilitate extractor interpretation; Provide clarity for users.
Use drop-down lists where possible To facilitate extraction; Avoid misspelling and proliferation of 
terms (e.g. Taznania/Tanzania/Rep. of Tanzania) for analysis.
Clarify differences 
in the data
Use key characteristics; Identify what is unique 
about costs if not a key characteristic
Users will want to be able to quickly understand why two or more 
cost estimates for the same intervention are different.
Note aberrations in the data (e.g. reported 
medians vs means; omitted unit cost inputs)
To facilitate comparability; Relevant data (e.g. personnel costs 
reported as $0) may not be in the first few columns of the 
extraction or shown on the first page of web results.
data drawn from extensive analysis of literature and primary 
data. While there is a filter for scale in the UCSR, so the 
user can identify the rare cases where an article did discuss 
or analyse scale, there are no calculations by the GHCC for 
scale in the UCSR. However, the GHCC data team has been 
looking into the issue of scale and presented results in a 
session entitled Moving Away from the Unit Cost: Estimating 
Country-Specific VMMC Average Cost per Service Curves 
Accounting for Variations in Implementing Platforms at the 
International Health Economics Association World Congress 
(Bautista-Arredondo et al., 2019).
Conclusion
The UCSR provides the only standardised and thoroughly 
validated repository of unit cost information from published 
HIV and TB literature. Documentation of the process and 
lessons learned from this endeavour may assist not only 
with the further refinement of the UCSR, but also with other 
cost data collection, collation, analysis, presentation, and 
utilisation efforts. One key lesson is that the extraction form 
and process have several advantages and disadvantages. 
The extraction template is comprehensive and flexible, while 
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offering opportunities for standardising author-reported 
content. However, there are several trade-offs when using 
such a comprehensive extraction template. First, the time 
required for each extraction is substantial, and there are 
more fields that need to be monitored for accuracy. Second, 
with multiple extractors, consistency across extractors 
required constant communication and frequent revisions of 
the template before reaching a stable form that minimised 
possible extraction differences. Since many of the fields 
in the UCSR are subjective, there were often differences 
among extractors in how data were extracted, even with 
extensive training of extractors and data quality checks. 
Table 4 provides a circumscribed set of recommendations 
for creating cost repositories, and thus directs practitioners 
toward focusing on: a) knowing their audience (e.g. what 
typologies/indicators they use for planning or budgeting, if 
they will want to conduct analysis with the data and what 
level of detail they will need, what types of platforms/
devices they access data on, what formats they will need 
data to be downloadable in for analysis and presentation), 
b) developing a process at the outset to ensure clear
communication both within and across data extraction and
UCSR design teams, c) clearly defining and standardising
each field used in the extraction, if possible in alignment
with the GHCC Reference Case, and with particular
attention given to the output units (unit cost denominators);
in addition to utilising drop-down lists wherever possible in
the extraction form and d) incorporating extraction fields and
web-design features to clarify differences in the data.
The process of standardising fields did often require 
ad-hoc review of author-reported content by intervention, 
and ongoing review of each intervention for themes and 
commonalities. As a result, version control of the extraction 
form became a priority as older interventions that were 
extracted prior to a given change needed to be updated. 
Accordingly, the GHCC created a system to contact the lead 
author of each study in the UCSR, ask them to review and 
validate the information presented, and then make edits to 
the extraction according to the author feedback. Note that 
the availability of “as reported” fields, in addition to GHCC 
standardised fields, was advantageous during the validation 
and data checking processes so that extracted costs in the 
original currency and cost categories could be checked back 
against the study. 
Several next steps can be recommended for future 
developments. First, due to the complexity of the existing 
extraction and validation process, the GHCC has explored 
systems for direct web-based data entry consisting of two 
activities: first, uploading a form to be completed by study 
author, and second, a quality review of entries by a senior 
GHCC staff member. This may result in a more sustainable 
approach for the UCSR and other cost repositories. 
Second, the GHCC has provided technical assistance, the 
GHCC Reference Case (inclusive of the checklist for how 
to transparently report cost estimates and key indicators 
critical to interpretation of cost estimates), and extraction 
and web-design templates to partners working to create 
cost repositories in immunisation, malaria, social and 
behavioural change (SBC), water, sanitation and hygiene 
(WASH), and country-level databases that incorporate 
further sources (e.g. National Strategic Plans, expenditure 
reporting). These databases could be integrated into 
the UCSR in the future, and lessons learned from how 
partners in immunisation, malaria, and SBC adapted the 
GHCC templates and conducted expedited cost repository 
processes were presented at the 2019 International Health 
Economics Association World Congress (DeCormier 
Plosky, Bollinger, Vaughan, Patouillard, & Vassall, 2019). 
In addition, due to the intervention-specific nuances to 
data extraction that make recording in a standard template 
challenging, the GHCC Reference Case delineation of 
interventions, activities, and outputs could be reviewed 
to better understand how broadly that standardisation can 
serve as a broader template. 
Finally, the UCSR displays unit costs as recorded; however, 
it does not provide guidance regarding which specific cost 
should be used. Although the UCSR has received excellent 
reviews for the quality of the product, greater discussion and 
testing with users, particularly at the country level, remain 
vitally important. User-centred design can better inform which 
tools and types of cost data have been or will be employed 
in country planning, reporting, and grant applications, how 
exactly these tools are utilised, and what kind of assistance 
will be most helpful in the years to come.
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Notes
1 See https://ghcosting.org/pages/standards/reference_case for 
more information on the Reference Case, and particularly Annex 
3 (listed under https://ghcosting.org/pages/standards/appendices/
standardized_TB_unit_costs ) for a listing of standardized 
disaggregated cost categories, using TB as an example.
2 In Boolean search terms the dash (e.g. –US) means “minus”.
3 Please see the paper by Drew Cameron in this special issue for 
more detail on the types (e.g. types of interventions, types of 
target populations, etc.) of HIV unit cost estimates and studies 
included in the UCSR and data gaps.
4 A Global HIV Intervention has recently been developed, which 
the Global AIDS Monitoring Typology maps to. A forthcoming 
update to the UCSR will incorporate the new Global HIV 
Intervention Typology.
5 Exchange rate data from <https://data.worldbank.org/indicator/
PA.NUS.FCRF>; and GDP Deflation Index data for each country 
from: <https://data.worldbank.org/indicator/NY.GDP.DEFL.ZS>.
6 The wide file is a single worksheet that has been exported to 
Excel from STATA. It contains column headings that align with 
each of the headings (fields) in the UCSR (filter headings, main 
result table headings, and headings found on each page in the 
second level display, and data in each row (associated with a 
unique unit cost) that provides the information for each heading.
7 These do not apply to studies using a patient perspective.
8 The UCSR is available at https://ghcosting.org/pages/data/ucsr/
app/
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Annex A: GHCC inflation procedure
There are different potential methods of inflating extracted 
and primary data to current USD for both HIV and TB 
data. The resulting prices are then used in the UCSR for 
reporting unit costs and inputs as well as for analysis. Given 
substantial variation in costs with the inflation methods 
described, a unified approach is recommended.
Following Kumaranayake,1 the general convention for 
inflating currency over time is to use either the US consumer 
price index (CPI) or the US gross domestic product (GDP) 
implicit price deflator. Figure A1 compares the use of both 
indices using the example of $100 USD in the year 2000 
inflated to 2016 USD (the most current year available at the 
time of the UCSR launch using World Bank data), resulting in 
2016 USD values of $139.38 for the CPI (a 39.4% increase 
over 16 years) and $136.06 for the GDP implicit price deflator 
(a 36.1% increase).2 Year-to-year inflation in the United 
States over this period was steady, ranging from –0.36% to 
3.8% for the CPI, and 0.76% to 3.22% for the GDP deflator. 
Most costs in the extracted and primary data collected by 
the GHCC are reported during this timeframe, thus the 
difference in values generated by either inflation method is 
slight. Nonetheless, a preference has been expressed by 
GHCC members for the GDP Implicit Price Deflator. The 
procedure for inflating costs using either index is to verify that 
all extracted and primary costs are first converted to USD 
in the reporting year. Then, multiply these costs by the ratio 
of the index in the reporting year to the index in the current 
year: e.g. the resulting values are then reported in 2016 USD 
given US inflation rates from the reporting year to present. 
Another method is to account for inflation within countries 
before converting to current USD. Kumaranayake discusses 
this briefly, noting that “…unless there is a situation of rapid 
inflation (e.g. 15–20% or higher), it is generally better to work 
in local currencies and then convert at the end (p. 234).” This 
procedure (referred to by the GHCC as the ‘Mozambique 
method’) requires first ensuring that data are in the country-
currency of data collection for the year of reporting, then 
inflating costs to 2016 in local currency (in our case, using 
the country-specific GDP implicit price deflator), then finally 
converting back to 2016 USD using the market exchange 
rate. As an example, Figure A2 uses the GDP implicit price 
deflator for Tanzania to illustrate the difference in inflation 
indices. First, the $100 figure is converted to Tanzanian 
shillings (TSh) in 2000 using the World Bank’s official 
exchange rates (LCU per USD), then the equivalent TSh 
value is inflated each year using the country-specific GDP 
deflator index from the World Bank, with 2000 as the base 
year for each inflation year from 2001–2016. Then each year 
is converted back to USD using the same official exchange 
rate conversion.3
While overall inflation from 2000 to 2016 is around twice 
the rate of inflation as the US (64.15%), resulting in $165.14 
in 2016 USD, year-to-year inflation varies substantially 
from a low of –0.0004% between 2010 and 2011, to a high 
of 20.66% between 2007 and 2008. Furthermore, there is 
both inflation and deflation during different year-to-year 
periods for Tanzania. Thus, costs recorded in any given year 
during this period in either extracted or primary data could 
experience drastically different rates or directions of inflation.
This pattern of inconsistent year-to-year inflation is not 
unique to Tanzania. Figure A3 uses the example of 11 of the 
12 sub-Saharan African countries for which the GHCC team 
extracted published cost data for voluntary medical male 
circumcision, and compares country inflation rates across all 
of these countries for the same $100 USD in the year 2000 
(Zimbabwe is not included because it abandoned its currency 
in 2009).4 Overall inflation is relatively similar to the US CPI 
and GDP inflation indices (39.4 and 36.1% respectively) in 
a number of countries (Swaziland, 27.9%; Namibia, 32.0%; 
Botswana, 36.8%; South Africa, 37.9%; Lesotho, 42.5%; 
Rwanda, 44.5%; and Uganda, 53.5%), while inflation was 
somewhat higher in Tanzania (65.2%), and substantially 
different in Mozambique (–32.0%), Zambia (114.4%) and 
Kenya (162.5%) by 2016. Further complicating matters, 
year-to-year inflation varies widely by country in the region. 
When comparing inflation methods by unit costs across 
countries for the extracted VMMC data, stark differences 
can be observed. Costs in countries like Uganda show 
the smallest (yet still large) differences between methods 
(GDP Deflator — mean: $31.88, range: $3.25 to $76.47; 
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Mozambique method — mean: $52.28, range: $5.86 to 
$116.96), while countries like Zambia, which underwent 
substantial inflation during this period, show drastic 
differences in inflation (GDP Deflator — mean: $70.54, 
range: $19.06 to $108.07; Mozambique method — mean: 
$242.51, range: $56.59 to $378.88). 
Given the substantially different year-to-year rates of 
inflation (many of which exceed the recommended 15-20% 
inflation rates mentioned by Kumaranayake), this method 
may not be advisable for all costs. An amalgamation of 
methods for different input costs has been suggested in 
which input costs such as personnel may be inflated using 
country-level inflation, and tradable goods could be inflated 
using US GDP or CPI inflation indices. In order to assess 
the feasibility of this approach, the GHCC tested generating 
inflated cost data collected by GHCC using variations of each 
exchange and inflation method and shared the resulting cost 
structures among the team. Ultimately, the GHCC decided 
that input cost reporting was too heterogenous across 
studies (with studies using various levels of specificity in 
reporting the source or type of input costs, if any) and that 
too many assumptions about the nature of these cost inputs 
was necessary to arrive at a thorough and replicable set of 
rules for the broad array of collected data. 
Notes
1 Kumaranayake, Lilani. (2000). How to do (or not to do) … The 
real and the nominal? Making inflationary adjustments to cost 
and other economic data. Health Policy and Planning, 15(2): 
230–234.
2 Figure A1 uses US CPI and US GDP deflator data from the 
World Bank, available online. US CPI data are available at 
<https://data.worldbank.org/indicator/FP.CPI.TOTL>, and data 
series displayed is “Consumer Price Index (2010 = 100)”.  US 
GDP Deflator data are available at: <https://data.worldbank.org/
indicator/NY.GDP.DEFL.ZS>, data series displayed is “GDP 
deflator (base year varies by country)”, and all country-level data 
exported by clicking on either CSV or EXCEL. For both series, 
only data for the United States are used to generate the figure. 
3 Exchange rate data comes from the World Bank Official 
Exchange Rate (LCU per US$), available online at <https://data.
worldbank.org/indicator/PA.NUS.FCRF>. Data are then inflated 
using local inflation using the GDP deflator. Data are available 
at <https://data.worldbank.org/indicator/NY.GDP.DEFL.ZS>, 
and the data series “GDP deflator (base year varies by country)” 
is used. Data are then converted back to USD using the same 
World Bank Official Exchange Rate data from above. Note that 
only in cases where the exchange rate is not reported do we use 
the WB exchange rates. These rates are the annual averages 
published on the World Bank website <https://data.worldbank.
org/indicator/PA.NUS.FCRF>.  If the date of the currency is not 
mentioned in the paper, we use the publication year minus one.
4 Figure A3 uses the same procedure as Figure A2, with country-
specific inflation data pulled from the same World Bank data 
source here: <https://data.worldbank.org/indicator/NY.GDP.
DEFL.ZS>.
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Figure A3: US$100 in year 2000 inflated to 2016 USD using US vs country-specific inflation (reported in USD)
